Clinical Trials Logo

Smoking clinical trials

View clinical trials related to Smoking.

Filter by:

NCT ID: NCT02939339 Completed - Smoking Clinical Trials

Theta Burst TMS as a Tool to Change Smoking Behavior

Start date: October 2015
Phase: Early Phase 1
Study type: Interventional

The goal of this study is to determine whether transcranial magnetic stimulation (TMS) is an effective treatment in decreasing craving in individuals who habitually smoke cigarettes. The study consists of six total visits to MUSC; one for the consent process, two that will include MRI scans, and five that will include TMS administration. Compensation will be provided for each visit.

NCT ID: NCT02932917 Enrolling by invitation - Smoking Clinical Trials

MapMySmoke: Smoking Cessation App With Geospatial Capture

Start date: June 2016
Phase: Phase 1
Study type: Interventional

Place-based cues can be an important trigger of smoking behavior, therefore the investigators wish to learn more about the influence of the built environment on individual smoking behavior. This is to facilitate dynamic support during the post-quit phase. MapMySmoke is a mobile phone application that enables the capture of spatial data during smoking and craving events. These data will be used to create individualized support plans via the app.

NCT ID: NCT02927847 Completed - Smoking Clinical Trials

Neuroimaging Reward, Behavioral Treatment, and Smoking Cessation

Start date: February 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this study is to evaluate the effects of a smoking cessation intervention combining behavioral treatment with low nicotine cigarettes on neuroimaging measures of reward function and smoking cessation outcomes. The results of this study will provide information about mechanisms contributing to smoking and smoking cessation and will help to guide future treatment studies.

NCT ID: NCT02922790 Completed - Smoking Clinical Trials

Feasibility and Smokers' Reactions to DNA Feedback

Start date: February 14, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to explore how feedback of cellular DNA (Deoxyribonucleic Acid) damage, as a marker of exposure to the genotoxic agents of tobacco smoke, promotes cessation.

NCT ID: NCT02916628 Terminated - Smoking Clinical Trials

Effects of Auricular Acupressure and Group Counseling on Smoking Cessation Tobacco Withdrawal Symptoms

Start date: July 2013
Phase: N/A
Study type: Interventional

Objective The purpose of this study is to examine the effects of auricular acupressure and group counseling with positive psychology and motivational interviewing on smoking cessation and tobacco withdrawal symptoms. Methods This study is a single blind randomized controlled trial. This study has been performed at a University in South Korea. 180 smokers and 60 non-smokers will be recruited. Smokers will be randomly assigned to three groups: group 1 (auricular acupressure + group counseling); group 2 (placebo acupressure + group counseling); and the control group (self-help smoking cessation). Group counseling is undertaken once per week for 6 weeks. Auricular acupressure using acupellets is performed for 6 weeks continuously.

NCT ID: NCT02912000 Completed - Obesity Clinical Trials

TEACH: Technology Evaluation to Address Child Health

TEACH
Start date: September 2016
Phase: N/A
Study type: Interventional

The proposed study is a pre- /post-implementation study in a pediatric practice with a control practice designed to test the feasibility and effectiveness of an electronic screening and service delivery tool for three modifiable health risk factors in pediatrics: parental tobacco use, sugar-sweetened beverages consumption, and poor dental care

NCT ID: NCT02901171 Completed - Smoking Clinical Trials

The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation

Start date: September 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of a smartphone application in enhancing Acceptance and Commitment Therapy group treatment for smoking cessation. This study also aims to elucidate the processes through which the treatment promotes smoking cessation and for whom it is most effective.

NCT ID: NCT02875782 Completed - Smoking Clinical Trials

Brief Intervention to Promote Smoking Cessation in DM Smokers

Start date: January 2011
Phase: N/A
Study type: Interventional

The study is a randomized controlled trial (RCT) on a tailored smoking cessation intervention targeted type 2 diabetic patients who smoke (DM intervention). The objectives are: 1. to study the effectiveness of the DM intervention in achieving (a) smoking cessation, (b) smoking reduction, and (c) progress to a higher stage of readiness to quit; 2. the changes in levels of HbA1c between (a) the intervention group and the controls, and (b) quitters and continuing smokers; 3. the predictive factors for the success of the outcomes above.

NCT ID: NCT02873754 Completed - Smoking Clinical Trials

Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)

Start date: January 2017
Phase: N/A
Study type: Interventional

This project proposes to evaluate the feasibility, acceptability, and efficacy of a mobile intervention to target smoking-cessation and increase physical activity among low-income persons. The intervention is called Smoking Treatment and Exercise Program for Underserved Populations (STEP UP).

NCT ID: NCT02866760 Completed - Smoking Clinical Trials

Helping In-patients to Quit Smoking by Understanding Their Risk Perception, Behavior, and Attitudes Related to Smoking

Start date: July 2016
Phase:
Study type: Observational

This study aims at understanding the needs and concerns of Chinese current smoking patients, including their risk perceptions, and the behavior, attitudes, and experiences related to smoking and smoking cessation. Specifically, how smokers overcome withdrawal symptoms and cigarette cravings, as a result of banning on smoking in hospitals, will be explored. In addition, whether smokers will stop, resume or continue smoking after hospitalization will be investigated.